| Financial Year |
March 31 2023 |
| Monetary Funds |
1,955,899,073.17 |
| Held-for-trading Financial Assets |
968,149,136.93 |
| Notes Receivable |
-- |
| Accounts Receivable |
96,087,648.11 |
| Advances to Suppliers |
28,411,492.41 |
| Other Receivables |
5,845,157.61 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
564,564,626.60 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
26,718,053.34 |
| Total Current Assets |
3,645,675,188.17 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
4,607,041.99 |
| Investment Properties |
-- |
| Fixed Assetes |
712,281,097.61 |
| Under-construction Projects |
128,533,027.21 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
296,939,759.91 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
64,054,035.84 |
| Deferred Income Tax Assets |
27,096,338.92 |
| Other Non-Current Assets |
2,125,189.18 |
| Sub-Total of Non-Current Assets |
1,269,960,527.99 |
| Total Assets |
4,915,635,716.16 |
| Short-Term Loans |
100,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,136,932,663.16 |
| Accounts Payable |
313,253,400.35 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
62,742,724.38 |
| Taxes Payable |
72,748,261.66 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
59,198,546.35 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
972,760.70 |
| Other Current Liabilities |
110,210,577.67 |
| Sub-Total of Current Liabilities |
1,900,548,076.60 |
| Long-term Loans |
4,325,956.70 |
| Bonds Payable |
464,177,252.81 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
2,159,237.86 |
| Deferred Income Tax Liabilities |
805,617.81 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
481,280,578.43 |
| Total Liabilities |
2,381,828,655.03 |
| Paid-In Capital(Or Share Stock) |
156,002,611.00 |
| Capital Surplus |
935,899,162.60 |
| Surplus Reserve |
78,222,000.00 |
| LESS:Treasury Stock |
76,863,098.01 |
| Undistributed Profits |
1,358,708,478.98 |
| Minority Stockholder's Interest |
159,955.98 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,533,647,105.15 |
| Owner's Equity（Stockholder's Equity） |
2,533,807,061.13 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,915,635,716.16 |
